Inhibition of TPA-induced NF-kappaB nuclear translocation and production of NO and PGE2 by the anti-rheumatic gold compounds (Q44358827)

2 December 2017

title

Inhibition of TPA-induced NF-kappaB nuclear translocation and production of NO and PGE2 by the anti-rheumatic gold compounds (English)

1 reference

2 December 2017

1 reference

Masamichi Yamashita

1 reference

2 December 2017

Shigeru Ashino

1 reference

2 December 2017

Yuko Oshima

1 reference

2 December 2017

Shunsuke Kawamura

1 reference

2 December 2017

Kazuo Ohuchi

1 reference

2 December 2017

Motoaki Takayanagi

1 reference

2 December 2017

publication date

1 February 2003

1 reference

Journal of Pharmacy and Pharmacology

2 December 2017

published in

1 reference

2 December 2017

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

245-251

1 reference

The mechanisms of action of disease-modifying antirheumatic drugs: A review with emphasis on macrophage signal transduction and the induction of proinflammatory cytokines

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Effects of anti-rheumatic gold salts on NF-kappa B mobilization and tumour necrosis factor-alpha (TNF-alpha)-induced neutrophil-dependent cytotoxicity for human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Auranofin. New oral gold compound for treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Inhibition of transcription factors by anti-inflammatory and anti-rheumatic drugs: can variability in response be overcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Thiol-reactive metal compounds inhibit NF-kappa B activation by blocking I kappa B kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Upstream NF-κB Site Is Required for the Maximal Expression of Mouse Inducible Nitric Oxide Synthase Gene in Interferon-γ plus Lipopolysaccharide-Induced RAW 264.7 Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Mechanism of action of disease modifying anti-rheumatic agent, gold sodium thiomalate (GSTM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

The NF-kappa B-binding site mediates phorbol ester-inducible transcription in nonlymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Cloning of Inducible Nitric Oxide Synthase in Rat Vascular Smooth Muscle Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Aurothioglucose inhibits induced NF-kB and AP-1 activity by acting as an IL-1 functional antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Auranofin inhibits interleukin-1beta-induced transcript of cyclooxygenase-2 on cultured human synoviocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Induction of nitric oxide synthase by lipopolysaccharide and its inhibition by auranofin in RAW 264.7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

HIV1 infection of human monocytes and macrophages promotes induction or translocation of NF-KB-related factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Auranofin inhibits the induction of interleukin 1 beta and tumor necrosis factor alpha mRNA in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Stimulation of prostaglandin E2 production by 12-O-tetradecanoylphorbol 13-acetate (TPA)-type and non-TPA-type tumor promoters in macrophages and its inhibition by cycloheximide

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Auranofin versus placebo in the treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Dual effects of auranofin on prostaglandin E2 production by rat peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Inhibition by auranofin of the production of prostaglandin E2 and nitric oxide in rat peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

Inhibition of IL-6 and IL-8 induction from cultured rheumatoid synovial fibroblasts by treatment with aurothioglucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F002235702513

21 January 2018

Identifiers

DOI

10.1211/002235702513

1 reference

2 December 2017

1 reference